BanderasNews
Puerto Vallarta Weather Report
Welcome to Puerto Vallarta's liveliest website!
Contact UsSearch
Why Vallarta?Vallarta WeddingsRestaurantsWeatherPhoto GalleriesToday's EventsMaps
 NEWS/HOME
 EDITORIALS
 ENTERTAINMENT
 VALLARTA LIVING
 PV REAL ESTATE
 TRAVEL / OUTDOORS
 HEALTH / BEAUTY
 HEALTH FOR WOMEN
 HEALTH FOR MEN
 DENTAL HEALTH
 ON ADDICTION
 RESOURCES
 SPORTS
 DAZED & CONFUSED
 PHOTOGRAPHY
 CLASSIFIEDS
 READERS CORNER
 BANDERAS NEWS TEAM
Sign up NOW!

Free Newsletter!
Puerto Vallarta News NetworkHealth & Beauty | September 2006 

A Drug to Help Premature Ejaculation?
email this pageprint this pageemail usLaura Owings - ABC News


In addition to lasting longer, the men felt they had more control over ejaculation and said both they and their partners reported more satisfaction.
Premature ejaculation is believed to be the most common male sexual dysfunction, affecting about 20 percent of young and middle-aged men. Yet despite these numbers, no drugs have been approved to treat this disorder.

But a new study published in the British medical journal the Lancet shows the drug dapoxetine may offer promise as a treatment for this debilitating condition.

Researchers at the University of Minnesota selected a group of more than 2,600 men who said they experienced severe premature ejaculation. This means that their ability to sustain sex before ejaculating averaged between zero to two minutes.

When these men took dapoxetine one to two hours before sexual activity, they experienced a three- to fourfold increase in performance time. In other words, compared with men who took a placebo and experienced an average of 1.75 minutes of intercourse, men taking 30 milligrams of dapoxetine averaged 2.78 minutes, and those taking a 60 milligram dosage lasted an average of 3.32 minutes.

In addition to lasting longer, the men felt they had more control over ejaculation and said both they and their partners reported more satisfaction.

These small increases are very important, especially for those who suffer from premature ejaculation, said the study's lead author, Dr. Jon Pryor, a professor and chairman of urologic surgery at the University of Minnesota.

"For these guys, that's huge for them," he said. "It's like night and day."

Pryor said that, like erectile dysfunction, premature ejaculation is a sensitive issue for many men with effects that extend beyond the bedroom.

"For people [for whom] this is a serious problem, they'll tell me 'It affects how I carry myself in public.' "

In some cases, relationships can bear the burden and marriages may be at risk.

The new drug's promising results and apparent low risk of side effects have already brought the drug some attention.

Andre Guay, director of the Center for Sexual Function and Endocrinology at the Lahey Clinic in Massachusetts, calls the findings "significant," adding, "any benefit is a plus for self-esteem and is a good beginning point to build on for the future. "

Johnson & Johnson, the drug's developer, funded the study, and the company is currently evaluating approval options for dapoxetine in the United States and other countries.

If eventually approved, it will be the first drug of its kind and will join the ranks of other sexual dysfunction drugs, such as Viagra and Cialis. It's hoped that dapoxetine will open the doors of awareness about sexual dysfunction, Pryor said.

Even if this drug is not approved, he hopes the study "will help people realize they are not alone."



In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving
the included information for research and educational purposes • m3 © 2008 BanderasNews ® all rights reserved • carpe aestus